Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04179 (
MnSOD
)
2,777
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mn superoxide dismutase
(
MnSOD
)-deficient mice (Sod2-/-) suffer from mitochondrial damage and have various survival times and phenotypic presentations that are dependent on the genetic background of the mutant mice. The mitochondrial NADPH transhydrogenase (
NNT
) was identified as a putative genetic modifier based on a genome-wide quantitative trait association study on the molecular defect of the protein in more severely affected Sod2-/- mice and on the biological function of
NNT
. Hence, Sod2-/- mice on the C57BL/6J (B6J) background have the shortest survival time, and the mice are homozygous for the truncated Nnt allele (Nnt ( T )). On the other hand, genetic backgrounds that support longer survival of Sod2-/- mice all have at least one normal copy of Nnt (Nnt ( W )). To confirm the role of
NNT
in the phenotypic modification of Sod2-/- mice, we introduced a normal copy of Nnt allele from a C57BL/6 substrain into B6J-Sod2-/- mice and analyzed survival time, cardiac functions, and histopathology of the heart. The study results show that the presence of a normal Nnt allele preserves cardiac function, delays the onset of heart failure, and extends the survival of B6J-Sod2-/- mice to the end of gestation. Postnatal survival, however, is not supported. Consequently, the majority of B6J-Sod2-/- mice died within a few hours after birth and only a few survived for 5-6 days. The study results suggest that
NNT
is important for normal development and function of fetal hearts and that there may be other genetic modifier(s) important for postnatal survival of Sod2-/- mice.
...
PMID:Genetic modifier of mitochondrial superoxide dismutase-deficient mice delays heart failure and prolongs survival. 2106 43